History

Since its establishment, ichrogene has developed solutions to prevent chronic diseases and cancers earlier using top global genetype analytics. We continue to spare no effort to offer disease prevention services using advanced bioengineering information, statistics and molecular biology while building gene digital bio-banking system. We will work to become a top global company to ensure safe and easy access gene information, which is regarded as the most fundamental source of healthcare.

8	Selected as an outsourcing company in charge of developing a guideline for strengthening data quality management by the Healthcare Research Resource Information Center at the Korea Centers for Disease Control and Prevention Approved CSA Star v4-internaional standard cloud security and reviewed v4 upgrade
7	Chosen as an outsourcing company by the Korea Disease Control and Prevention Agency in the project of "development of cohort track and management model using Digital Twin" Genetype analytics pipeline (Igap-on-cloud) was launched on Naver Cloud marketplace. Performed outsourced work in connection with the leading project holding genetypes as part of national biological big data pilot project organized by the Korea Research Institute of Bioscience and Biotechnology Chosen as one of eligible companies under the SME technological development support project, developed AI-based Two-type diabetes complication risk prediction service
6	Signed MOU with the KSPONCO for cooperating in the development and operation of future sports center new project
5	Signed MOU and partnership with Thai healthcare startup Bluepin Life Technology
4	Approved ISo 9001-International Standard Quality Management System
3	Approved ISO 27001-International standards information security management CSA Star-Approved international standard cloud security
1	Joined the Thai Ministry of Education PMU-C(healthcare) project (Naver Cloud Consortium)

12	Selected as a service provider tasked with creating and analyzing genetype data used to study the correlation between
9	The Korea Centers for Disease Control and Prevention transferred Two-type diabetes genetic high-risk group analysis patented technology Selected as a business dealing with strengthening data quality management of National Biobank of Koreaand advancing rental data management system Outsourcing business dealing with creating and analyzing personal genetype information used for blockchain-based medical MyData contactless platform services
8	Outsourcing business dealing with creating and analyzing personal genetype information used for building multimodal AI-based data for diagnosing mental health
6	Selected as an eligible company for subsidized project as part of venture kickoff support program
5	Selected as a business organizing K-Data medical MyData authentication project
3	Attracted KRW3 billion in A Series investment by Insight Equity Partners
1	Signed MOU with Gwangju City for creating AI industry complex

12	Selected as a business in charge of building AI-based healthcare plarform in Gwangju City
5	No.371 gene test company designated by the Korea Disease Control and Prevention Agency under the Ministry of Health and Welfare
3	iSearchme gene data analysis global service was launched.
2	Awarded Top in K-Startup Investment Parade

12	Attracted KRW1.1 billion investment of Free Series- New Flight, Naver, Genopsy and 365mc
11	Awared Top Prize at Anti-aging Health Startup Fair organized by Hankuk Gyungjae TV
10	Signed MOU and technology transfer with the AI lab at Korea University
8	Approved by the Korea Disease Control and Prevention Agency under the Ministry of Health and Welfare Founded ichrogene IRB ethics committee
6	Founded ichrogene USA branch office in Virginia, US Selected as First Penguin by the Korea Credit Guarantee Fund

10	Selected as top in the 2018 Digital Innovation Award hosted by Hankook Ilbo
6	Selected as KIC (Korean Innovation Center) startup accelerator
5	Venture company approved by the Kibo Technology Fund

12	Selected as promising business in ICT (K-Global300) approved by the Ministry of Science and ICT.
9	Joined the KIC (Korean Innovation Center) startup accelerator
8	Selected as Bio I-Corps global venture tasks in the biological/medical technology development project organized by the Ministry of Science and ICT Established ichrogene, Inc.
5	Selected as Bio I-Corps global venture tasks in the biological/medical technology development project organized by the Ministry of Science, ICT and Future Planning